Small Cap Catch-Up: Diagnostics, Bricks and Switches
Mark Watson-Mitchell ends the week with a look at Medica, Michelmersh, UP and Strix.
Mark Watson-Mitchell ends the week with a look at Medica, Michelmersh, UP and Strix.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
It has been a volatile few months to be invested in the UK equity income sector, with the latest setback being the risk of a banking crisis following the collapse of Silicon Valley Bank.
Brokers believe this company could triple its profits during the current year. Mark Watson-Mitchell takes a closer look.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
For many investment trusts 2022 was a year to forget, but that was certainly not the case for the $1.4bn BioPharma Credit, which was able to declare record distributions for its shareholders.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Mark Watson-Mitchell inspects this equity trading at 9 times P/E with 4% yield and no debt.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Labour says we are back to the 1970s, and that the UK is once again “the sick man of Europe”. Is that fair, asks Victor Hill?